Overview

Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon

Status:
Completed

Trial end date:
2020-01-16

Target enrollment:

Participant gender:

Summary

This study aims to evaluate potential predictors of adherence by investigating a representative cohort of MS patients in Germany treated with Betaferon

Details

Lead Sponsor:

Bayer

Treatments:

Interferon beta-1b
Interferon-beta
Interferons